Augment Intelligent Medical System (China) Co., Ltd. (AIMS) is a high-tech company funded and established in China in 2018 by an international team of medical robotics experts. By integrating over 20 years of research achievements in the field of intelligent healthcare and surgical robotics from research institutions in Singapore, Europe and the United States, we have built a highly integrated and interdisciplinary "Technology Middle Platform" for intelligent minimally invasive surgical robots, making the widespread application of high-end intelligent medical technology a reality.

      Based on the "Technology Middle Platform," AIMS has launched a series of intelligent minimally invasive surgical robot products, covering various fields such as the interventional treatment of malignant diseases in major human organs. The treatment process does not require cutting the affected organs, effectively avoiding cancer cell spreading and organ function loss caused by traditional surgical treatments. This breakthrough overcomes the limitations of traditional manual treatment methods and assists doctors in offering more precise, efficient, and convenient cancer detection and treatment services.In 2020, AIMS obtained national-level recognition as a high-tech enterprise.